Clinical Trials Directory

Trials / Unknown

UnknownNCT06100003

A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method

A Real-world Observational Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method

Status
Unknown
Phase
Study type
Observational
Enrollment
104 (estimated)
Sponsor
Funan Liu · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

The study is a real-world observational clinical study. Patients diagnosed as gastric cancer through histopathology were screened and enrolled. Before anti-tumor treatment, gastroscopy biopsy tissue specimens, surgical specimens, and malignant pleural effusion or ascites specimens, etc. are collected. The investigators will perform a drug sensitivity testing based on a novel drug susceptibility testing method to test the commonly used anti-tumor treatment regimens. Patients were given conventional anti-tumor treatment according to the medical judgment of the doctors. Finally, the investigator will evaluate the consistency of clinical efficacy in gastric cancer treatment and drug susceptibility outcomes.

Conditions

Timeline

Start date
2023-10-18
Primary completion
2025-10-31
Completion
2025-12-01
First posted
2023-10-25
Last updated
2024-02-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06100003. Inclusion in this directory is not an endorsement.